NATIONAL INSTRUMENTS CORP - FORM 8-K - EX-99.1 - PRESS RELEASE

Attached files

file	filename
8-K - NATIONAL INSTRUMENTS CORPORATION - FORM 8-K - NATIONAL INSTRUMENTS CORP	form8-k.htm

Contact:		Caitlin Gursslin
		Investor Relations
		(512) 683-8456

National Instruments Reports Record Annual and Quarterly Revenue

Company Drives Product Adoption Through Growth in Orders Over $20,000

AUSTIN, Texas – Jan. 31, 2013

Q4 2012 Highlights

·	Record revenue of $300 million, up 8 percent year-over-year on a GAAP basis and 7 percent year-over-year on a non-GAAP basis

·	GAAP gross margin of 75.2 percent and non-GAAP gross margin of 76.0 percent

·	Fully diluted GAAP EPS of $0.17

·	Fully diluted non-GAAP EPS of $0.29

·	EBITDA of $45 million, or $0.37 per share

·	$335 million in cash and short-term investments as of Dec. 31, 2012

National Instruments (Nasdaq: NATI) today announced record Q4 revenue of $300 million, an increase of 8 percent year-over-year on a GAAP basis and up 7 percent year-over-year on a non-GAAP basis. In Q4, orders between $20,000 and $100,000 were up by 6 percent year-over-year while orders over $100,000 grew 37 percent year-over-year. The company’s orders less than $20,000 decreased by 1 percent year-over-year, reflecting the continued weakness in the Global PMI in Q4.

GAAP net income was $21 million in Q4, with fully diluted earnings per share (EPS) of $0.17. Included in the GAAP results is a $6.8 million, or $0.06 per share, adjustment to the acquisition earn-out accrual related to NI’s acquisition of AWR in June 2011. This increase in the accrual is a result of AWR’s performance exceeding the company’s prior expectations.

Non-GAAP net income for Q4 was $35 million, with non-GAAP fully diluted EPS of $0.29. The company’s non-GAAP results exclude the impact of stock-based compensation, amortization of acquisition-related intangibles, acquisition accounting for deferred revenue, acquisition earn-out accrual, and acquisition-related transaction costs. Reconciliations of the company’s GAAP and non-GAAP results are included as part of this news release.

A significant contributor to National Instruments’ success this year was winning the largest application sale in the history of the company. This application involves the use of NI LabVIEW system design software and the NI PXI hardware platform to rapidly develop a production test solution. In 2012, National Instruments received $59 million in orders for this application, and the company believes it will receive significant future orders from this customer during 2013.

“Since we founded the company in 1976, the role NI technology plays in building measurement systems has evolved substantially to best fit the changing needs of our customers,” said Dr. James Truchard, NI president, CEO and co-founder. “I remain optimistic that our differentiated approach through graphical system design, the industry shift away from rack-and-stack to a modular approach and our on-going commitment to customer success continue to set National Instruments apart from others in our industry.”

As the company previously announced, on Oct. 1, 2012, National Instruments created a new geographical territory in Asia, resulting in four regions: Americas, Europe, East Asia and Emerging Markets. Geographically, revenue in U.S. dollar terms for Q4 2012 compared to Q4 2011 was up 3 percent in the Americas, down 8 percent in Europe, up 24 percent in East Asia and up 42 percent in Emerging Markets. In local currency terms, revenue was down 5 percent in Europe, up 25 percent in East Asia and up 33 percent in Emerging Markets.

As of Dec. 31, NI had $335 million in cash and short-term investments, decreasing by $29 million from Q3. During the quarter, National Instruments paid $25 million for several acquisitions, including Signalion; distributed $17 million for dividends; and invested $10 million in the completion of its new manufacturing facility and the purchase of additional property. The National Instruments Board of Directors approved a quarterly dividend of $0.14 per share on the company’s common stock payable on March 11 to shareholders of record on Feb. 19.

National Instruments Reports Record Annual and Quarterly Revenue

Jan. 31, 2013

Page 2

FY 2012 Highlights

·	Record revenue of $1.14 billion, up 12 percent year-over-year on a GAAP basis and up 10 percent year-over-year on a non-GAAP basis

·	GAAP gross margin of 75.5 percent

·	Non-GAAP gross margin of 76.4 percent

·	GAAP operating margin of 10 percent

·	Non-GAAP operating margin of 14.4 percent

·	Fully diluted GAAP EPS of $0.73

·	Fully diluted non-GAAP EPS of $1.03

·	Record annual revenue for PXI, CompactRIO and CompactDAQ products

·	NI named to the Great Place to Work Institute’s 25 Best Multinational Companies to Work For list for the second consecutive year and its 100 Best Companies to Work For list for the 14th consecutive year

Full-year 2012 revenue was $1.14 billion, up 12 percent year-over-year on a GAAP basis and up 10 percent year-over-year on a non-GAAP basis. GAAP net income for 2012 was $90 million, with fully diluted GAAP EPS of $0.73, and non-GAAP net income was $127 million, with non-GAAP fully diluted EPS of $1.03.

“We believe our ability to grow revenue and maintain our operating profit in 2012, despite significant economic headwinds, demonstrated the strength of our disruptive approach,” said Alex Davern, EVP, COO and CFO. “Our goals for 2013 are to continue to leverage the investments we have already made to drive sustained revenue growth and to continue to drive toward our long-term target of 18 percent non-GAAP operating income.”

Guidance for Q1 2013

The company continues to be cautious in planning for 2013 and anticipates the Global PMI to remain weak through Q2. NI currently expects Q1 revenue to be between $276 million and $296 million. The company expects fully diluted GAAP EPS between $0.12 and $0.22, with non-GAAP fully diluted EPS expected to be between $0.19 and $0.29. Included in the guidance for Q1 is a $0.03 per share benefit from the recognition of the 2012 benefit of the R&D tax credit in Q1 2013.

Non-GAAP Presentation

In addition to disclosing results determined in accordance with GAAP, NI discloses certain non-GAAP operating results and non-GAAP information that exclude certain charges. In this news release, the company has presented its revenue, gross profit, gross margin, operating expenses, operating income, operating margin, income before income taxes, provision for income taxes, net income and basic and fully diluted EPS for the three- and 12-month periods ending Dec. 31, 2012 and 2011, on a GAAP and non-GAAP basis. NI is also providing guidance on its non-GAAP fully diluted EPS. When presenting non-GAAP information, the company includes a reconciliation of the non-GAAP results to the GAAP results. Management believes that including the non-GAAP results assists investors in assessing the company’s operational performance and its performance relative to its competitors. The company presents these non-GAAP results as a complement to results provided in accordance with GAAP, and these results should not be regarded as a substitute for GAAP. Management uses these non-GAAP measures to manage and assess the profitability and performance of its business and does not consider stock-based compensation expense, amortization of acquisition-related intangibles, acquisition accounting for deferred revenue, adjustments related to the company’s contract dispute with the GSA, acquisition-related adjustments and acquisition-related transaction costs in managing its operations. Specifically, management uses non-GAAP measures to plan and forecast future periods, to establish operational goals, to compare with its business plan and individual operating budgets, to measure management performance for the purposes of executive compensation including payments to be made under bonus plans, to assist the public in measuring the company’s performance relative to the company’s long-term public performance goals, to allocate resources and, relative to the company’s historical financial performance, to enable comparability between periods. Management also considers such non-GAAP results to be an important supplemental measure of its performance.

This news release also discloses the company’s earnings before interest, taxes, depreciation and amortization (EBITDA) and EBITDA diluted EPS for the three- and 12-month periods ended Dec. 31, 2012 and 2011. The company believes that including the EBITDA results assists investors in assessing the company’s operational performance relative to its competitors. A reconciliation of EBITDA and EBITDA diluted EPS to GAAP net income and GAAP diluted EPS is included with this news release.

National Instruments Reports Record Annual and Quarterly Revenue

Jan. 31, 2013

Page 3

Conference Call Information

Interested parties can listen to the Q4 2012 conference call today, Jan. 31, beginning at 4:00 p.m. CST, at ni.com/call. Additionally, a replay will be available shortly after the call ends through Feb. 5 at 7:00 p.m. CST by calling (855) 859-2056, confirmation code #85756419, or by visiting the company's website at ni.com/call.

Forward-Looking Statements

This release contains “forward-looking statements,” including statements related to the company’s belief it will receive significant future orders from a large customer during 2013, remaining optimistic that its differentiated approach sets NI apart from others in the industry; the strength of the company’s disruptive approach; the company’s goals for 2013; NI’s drive toward its long-term target of 18 percent non-GAAP operating income; anticipated weakness in the Global PMI through Q2; and NI’s Q1 guidance for revenue, GAAP and non-GAAP EPS, and expected benefit from the 2012 R&D tax credit. These statements are subject to a number of risks and uncertainties, including the risk of adverse changes or fluctuations in the global economy, component shortages, delays in the release of new products, fluctuations in customer demand for NI products, the company’s ability to effectively manage its operating expenses, manufacturing inefficiencies, adjustments to acquisition earn-out accruals, foreign exchange fluctuations and the impact of NI’s recent and any future acquisitions. Actual results may differ materially from the expected results.

The company directs readers to its Form 10-K for the fiscal year ended Dec. 31, 2011, its Form 10-Q for the quarter ended Sept. 30, 2012, and the other documents it files with the SEC for other risks associated with the company’s future performance.

About National Instruments

Since 1976, National Instruments (www.ni.com) has equipped engineers and scientists with tools that accelerate productivity, innovation and discovery. NI’s graphical system design approach to engineering provides an integrated software and hardware platform that speeds the development of any system needing measurement and control. The company’s long-term vision and focus on improving society through its technology supports the success of its customers, employees, suppliers and shareholders. Readers can obtain investment information from the company’s investor relations department by calling (512) 683-5090, emailing nati@ni.com or visiting www.ni.com/nati. (NATI-F)

CompactRIO, LabVIEW, National Instruments, NI and ni.com are trademarks of National Instruments. Other product and company names listed are trademarks or trade names of their respective companies.

###

National Instruments
Consolidated Balance Sheets
(in thousands)

		Dec. 31, 2012		Dec. 31,
		(unaudited)		2011
Assets
Current assets:
Cash and cash equivalents	$	161,996	$	142,608
Short-term investments		173,166		223,504
Accounts receivable, net		187,060		157,056
Inventories, net		169,990		131,995
Prepaid expenses and other current assets		48,009		38,082
Deferred income taxes, net		27,479		26,304
Total current assets		767,700		719,549

Property and equipment, net		249,721		190,148
Goodwill		147,258		130,747
Intangible assets, net		93,913		83,866
Other long-term assets		26,177		29,984
Total assets	$	1,284,769	$	1,154,294

Liabilities and Stockholders’ Equity
Current liabilities:
Accounts payable	$	65,080	$	41,111
Accrued compensation		29,978		29,616
Deferred revenue – current		90,714		80,059
Accrued expenses and other liabilities		34,373		37,612
Other taxes payable		24,811		24,507
Total current liabilities		244,956		212,905

Deferred income taxes		47,630		43,186
Liability for uncertain tax positions		20,920		19,494
Deferred revenue – long-term		20,446		10,015
Other long-term liabilities		11,689		16,683
Total liabilities	$	345,641	$	302,283

Stockholders’ equity:
Preferred stock	$	-	$	-
Common stock		1,229		1,207
Additional paid-in capital		532,845		471,830
Retained earnings		404,210		382,474
Accumulated other comprehensive income (loss)		844		(3,500)
Total stockholders’ equity	$	939,128	$	852,011
Total liabilities and stockholders’ equity	$	1,284,769	$	1,154,294

National Instruments
Consolidated Statements of Income
(in thousands, except per share data)

		Three Months Ended				12 Months Ended
		Dec. 31,				Dec. 31,
		(Unaudited)				(Unaudited)
		2012		2011		2012		2011
Net sales:
Product	$	278,641	$	256,606	$	1,054,849	$	955,613
Software maintenance		21,685		21,445		87,494		81,667
GSA accrual		-		-		1,349		(13,107)
Total net sales		300,326		278,051		1,143,692		1,024,173

Cost of sales:
Product	$	73,465	$	66,499	$	274,839	$	235,839
Software maintenance		1,116		888		5,435		5,125
Total cost of sales		74,581		67,387		280,274		240,964

Gross profit	$	225,745	$	210,664	$	863,418	$	783,209

Operating expenses:
Sales and marketing	$	111,447	$	102,221	$	431,468	$	388,768
Research and development		58,066		54,502		222,994		199,071
General and administrative		21,649		21,439		85,239		82,658
Acquisition-related adjustment		6,783		-		6,783		-
Total operating expenses	$	197,945	$	178,162	$	746,484	$	670,497

Operating income	$	27,800	$	32,502	$	116,934	$	112,712

Other income (expense):
Interest income	$	221	$	280	$	716	$	1,319
Net foreign exchange (loss)		(107)		(1,338)		(2,246)		(2,755)
Other income, net		77		78		(567)		(142)

Income before income taxes	$	27,991	$	31,522	$	114,837	$	111,134

Provision for (benefit from) income taxes		7,278		7,195		24,700		17,062

Net income	$	20,713	$	24,327	$	90,137	$	94,072

Basic earnings per share	$	0.17	$	0.20	$	0.74	$	0.79
Diluted earnings per share	$	0.17	$	0.20	$	0.73	$	0.78

Weighted average shares outstanding –
Basic		122,754		120,582		121,973		119,836
Diluted		123,375		121,453		122,977		121,220

Dividends declared per share	$	0.14	$	0.10	$	0.56	$	0.40

National Instruments
Consolidated Statements of Cash Flows
(in thousands)
		12 Months Ended
		Dec. 31,
		(Unaudited)
		2012		2011
Cash flow from operating activities:
Net income	$	90,137	$	94,072
Adjustments to reconcile net income to net cash provided
by operating activities:
Depreciation and amortization		58,686		49,897
Stock-based compensation		27,796		23,219
Tax expense (benefit) from deferred income taxes		1,853		(8,581)
Tax (benefit) from stock option plans		(2,198)		(5,151)
Changes in operating assets and liabilities:
Accounts receivable		(26,007)		(21,957)
Inventories		(36,154)		(11,817)
Prepaid expenses and other assets		(7,037)		(1,350)
Accounts payable		23,419		5,573
Deferred revenue		604		16,953
Taxes and other liabilities		1,417		29,041
Net cash provided by operating activities	$	132, 516	$	169,899

Cash flow from investing activities:
Capital expenditures		(89,073)		(54,830)
Capitalization of internally developed software		(11,721)		(12,065)
Additions to other intangibles		(1,890)		(5,035)
Acquisitions, net of cash received		(25,481)		(73,558)
Purchases of short-term investments		(188,098)		(257,449)
Sales and maturities of short-term investments		238,436		166,104
Net cash provided/(used) by investing activities	$	(77,827)	$	(236,833)

Cash flow from financing activities:
Proceeds from issuance of common stock		30,902		32,905
Dividends paid		(68,401)		(47,961)
Tax benefit from stock option plans		2,198		5,151
Net cash used by financing activities	$	(35,301)	$	(9,905)

Net change in cash and cash equivalents		19,388		(76,839)
Cash and cash equivalents at beginning of period		142,608		219,447
Cash and cash equivalents at end of period	$	161,996	$	142,608

Detail of GAAP Charges Related to Revenue, Stock-Based Compensation,
Amortization of Acquisition Intangibles and Acquisition-Related Transaction Costs
(in thousands)
(unaudited)


		Three Months Ended			12 Months Ended
		Dec. 31,			Dec. 31,
		2012		2011		2012		2011
Revenue
Acquisition-related deferred revenue	$	-	$	1,912	$	2,156	$	4,730
GSA accrual		-		-		(1,349)		13,107
Provision for income taxes		-		(669)		(282)		(6,242)
Total	$	-	$	1,243	$	525	$	11,595

Stock-based compensation
Cost of sales	$	430	$	411	$	1,719	$	1,527
Sales and marketing		3,033		2,702		11,612		9,711
Research and development		2,919		2,625		10,909		8,870
General and administrative		908		831		3,556		3,111
Provision for income taxes		(2,193)		(2,041)		(7,579)		(6,827)
Total	$	5,097	$	4,528	$	20,217	$	16,392


Amortization of acquisition intangibles
Cost of sales	$	2,165	$	2,469	$	8,926	$	7,064
Sales and marketing		476		447		1,819		1,071
Research and development		217		-		217		-
Other income, net		194		190		765		955
Provision for income taxes		(964)		(993)		(3,717)		(2,736)
Total	$	2,088	$	2,113	$	8,010	$	6,354

Acquisition-related transaction costs
Cost of sales	$	(56)	$	32	$	(24)	$	54
Sales and marketing		177		220		606		1,349
Research and development		165		106		360		176
General and administrative		355		47		393		505
Acquisition-related adjustment		6,783		-		6,783		-
Provision for income taxes		(105)		(142)		(348)		(288)
Total	$	7,319	$	263	$	7,770	$	1,796

National Instruments
Reconciliation of GAAP to Non-GAAP Measures
(in thousands, except per share data)
(unaudited)

			Three Months Ended					12 Months Ended
			Dec. 31,					Dec. 31,
			2012			2011		2012				2011
Reconciliation of Net Sales to Non-GAAP Net Sales
Net sales, as reported	$		300,326	$		278,051	$	1,143,692			$	1,024,173
Acquisition-related deferred revenue			-			1,912		2,156				4,730
GSA accrual			-			-		(1,349)				13,107
Non-GAAP net sales	$		300,326	$		279,963	$	1,144,499			$	1,042,010

Reconciliation of Gross Profit to Non-GAAP Gross Profit
Gross profit, as reported	$		225,745	$		210,664	$	863,418			$	783,209
Acquisition-related deferred revenue and GSA accrual			-			1,912		807				17,837
Stock-based compensation			430			411		1,719				1,527
Amortization of acquisition intangibles			2,165			2,469		8,926				7,064
Acquisition-related transaction costs			(56)			32		(24)				54
Non-GAAP gross profit	$		228,284	$		215,488	$	874,846			$	809,691
Non-GAAP gross margin			76%			77%		76%				78%

Reconciliation of Operating Expenses to Non-GAAP Operating Expenses
Operating expenses, as reported	$		197,945	$		178,162	$	746,484			$	670,497
Stock-based compensation			(6,860)			(6,158)		(26,077)				(21,692)
Amortization of acquisition intangibles			(693)			(447)		(2,036)				(1,071)
Acquisition-related adjustment			(6,783)			-		(6,783)				-
Acquisition-related transaction costs			(697)			(373)		(1,359)				(2,030)
Non-GAAP operating expenses	$		182,912	$		171,184	$	710,229			$	645,704

Reconciliation of Operating Income to Non-GAAP Operating Income
Operating income, as reported		$	27,800	$		32,502	$	116,934			$	112,712
Acquisition-related deferred revenue and GSA accrual			-			1,912		807				17,837
Stock-based compensation			7,290			6,569		27,796				23,219
Amortization of acquisition intangibles			2,858			2,916		10,962				8,135
Acquisition-related adjustment			6,783			-		6,783				-
Acquisition-related transaction costs			641			405		1,335				2,084
Non-GAAP operating income		$	45,372	$		44,304	$	164,617			$	163,987
Non-GAAP operating margin			15%			16%		14%				16%

Reconciliation of Income Before Income Taxes to Non-GAAP Income Before Income Taxes
Income before income taxes, as reported		$	27,991	$	31,522		$		114,837		$	111,134
Acquisition-related deferred revenue and GSA accrual			-		1,912					807		17,837
Stock-based compensation			7,290		6,569					27,796		23,219
Amortization of acquisition intangibles			3,052		3,106					11,727		9,090
Acquisition-related adjustment			6,783		-					6,783		-
Acquisition-related transaction costs			641		405					1,335		2,084
Non-GAAP income before income taxes		$	45,757	$	43,514		$			163,285	$	163,364

Reconciliation of Provision for Income Taxes to Non-GAAP Provision for Income Taxes
Provision for (benefit from) income taxes, as reported		$	7,278	$		7,195	$			24,700	$	17,062
Acquisition-related deferred revenue and GSA accrual			-			669				282		6,242
Stock-based compensation			2,193			2,041				7,579		6,827
Amortization of acquisition intangibles			964			993				3,717		2,736
Acquisition-related transaction costs			105			142				348		288
Non-GAAP provision for income taxes		$	10,540	$		11,040	$			36,626	$	33,155

Reconciliation of GAAP Net Income, Basic EPS and Diluted EPS to Non-GAAP Net Income, Basic EPS and Diluted EPS
(in thousands, except per share data)

(unaudited)

		Three Months Ended				12 Months Ended
		Dec. 31,				Dec. 31,
		2012		2011		2012		2011
Net income, as reported	$	20,713	$	24,327	$	90,137	$	94,072
Adjustments to reconcile net income to non-GAAP net income:
Acquisition-related deferred revenue and GSA accrual, net of tax effect		-		1,243		525		11,595
Stock-based compensation, net of tax effect		5,097		4,528		20,217		16,392
Amortization of acquisition intangibles, net of tax effect		2,088		2,113		8,010		6,354
Acquisition-related adjustment		6,783		-		6,783		-
Acquisition-related transaction costs, net of tax effect		536		263		987		1,796
Non-GAAP net income	$	35,217	$	32,474	$	126,659	$	130,209

Basic EPS, as reported	$	0.17	$	0.20	$	0.74	$	0.79
Adjustment to reconcile basic EPS to non-GAAP basic EPS:
Impact of acquisition-related deferred revenue and GSA accrual, net of tax effect		-		0.01		0.00		0.10
Impact of stock-based compensation, net of tax effect		0.04		0.04		0.16		0.14
Impact of amortization of acquisition intangibles, net of tax effect		0.02		0.02		0.07		0.05
Impact of acquisition-related adjustment		0.06		-		0.06		-
Impact of acquisition-related transaction costs, net of tax effect		-		-		0.01		0.01
Non-GAAP basic EPS	$	0.29	$	0.27	$	1.04	$	1.09


Diluted EPS, as reported	$	0.17	$	0.20	$	0.73	$	0.78
Adjustment to reconcile diluted EPS to non-GAAP diluted EPS:
Impact of acquisition-related deferred revenue, net of tax effect		-		0.01		0.00		0.10
Impact of stock-based compensation, net of tax effect		0.04		0.04		0.16		0.13
Impact of amortization of acquisition intangibles, net of tax effect		0.02		0.02		0.07		0.05
Impact of acquisition-related adjustment		0.06		-		0.06		-
Impact of acquisition-related transaction costs, net of tax effect		-		-		0.01		0.01
Non-GAAP diluted EPS	$	0.29	$	0.27	$	1.03	$	1.07

Weighted average shares outstanding -
Basic		122,754		120,582		121,973		119,836
Diluted		123,375		121,453		122,977		121,220

Reconciliation of Net Income and Diluted EPS to EBITDA and EBITDA Diluted EPS
(in thousands, except per share data)
(unaudited)

		Three Months Ended				12 Months Ended
		Dec. 31,				Dec. 31,
		2012		2011		2012		2011
Net income, as reported	$	20,713	$	24,327	$	90,137	$	94,072
Adjustments to reconcile net income to EBITDA:
Interest income		(221)		(280)		(716)		(1,319)
Taxes		7,278		7,195		24,700		17,062
Depreciation and amortization		17,657		14,152		58,686		49,897
EBITDA	$	45,427	$	45,394	$	172,807	$	159,712

Diluted EPS, as reported	$	0.17	$	0.20	$	0.73	$	0.78
Adjustment to reconcile diluted EPS to EBITDA:
Interest income		-		(0.01)		(0.00)		(0.01)
Taxes		0.06		0.06		0.20		0.14
Depreciation and amortization		0.14		0.12		0.48		0.41
EBITDA diluted EPS	$	0.37	$	0.37	$	1.41	$	1.32

Weighted average shares outstanding - diluted		123,375		121,453		122,977		121,220

National Instruments
Reconciliation of GAAP to Non-GAAP EPS Guidance
(unaudited)

		Three months ended
		March 31, 2013
		Low		High
GAAP fully diluted EPS, guidance	$	0.12	$	0.22
Adjustment to reconcile diluted EPS to non-GAAP diluted EPS:
Impact of stock-based compensation, net of tax effect		0.05		0.05
Impact of amortization of acquisition intangibles, net of tax effect		0.02		0.02

Non-GAAP diluted EPS, guidance	$	0.19	$	0.29

NATIONAL INSTRUMENTS CORP - FORM 8-K - EX-99.1 - PRESS RELEASE - January 31, 2013

Attached files

NATIONAL INSTRUMENTS CORP Reports